Jiangsu Kanion Pharmaceutical Co (SHSE:600557) EV-to-Revenue

: 1.93 (As of Today)

View and export this data going back to 2002. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Jiangsu Kanion Pharmaceutical Co's enterprise value is ¥9,426 Mil. Jiangsu Kanion Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥4,874 Mil. Therefore, Jiangsu Kanion Pharmaceutical Co's EV-to-Revenue for today is 1.93.

The historical rank and industry rank for Jiangsu Kanion Pharmaceutical Co's EV-to-Revenue or its related term are showing as below:

SHSE:600557' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.3 Med: 2.44 Max: 7.89
Current: 1.93

During the past 13 years, the highest EV-to-Revenue of Jiangsu Kanion Pharmaceutical Co was 7.89. The lowest was 1.30. And the median was 2.44.

SHSE:600557's EV-to-Revenue is ranked better than
56.14% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.28 vs SHSE:600557: 1.93

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-23), Jiangsu Kanion Pharmaceutical Co's stock price is ¥18.52. Jiangsu Kanion Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥8.24. Therefore, Jiangsu Kanion Pharmaceutical Co's PS Ratio for today is 2.25.

Jiangsu Kanion Pharmaceutical Co EV-to-Revenue Historical Data

The historical data trend for Jiangsu Kanion Pharmaceutical Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Kanion Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

2.01

1.95

1.79

2.15

2.00

Jiangsu Kanion Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															3.73	2.93	2.15	2.00	2.01

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Kanion Pharmaceutical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jiangsu Kanion Pharmaceutical Co EV-to-Revenue Distribution

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Kanion Pharmaceutical Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Jiangsu Kanion Pharmaceutical Co's EV-to-Revenue falls into.

Jiangsu Kanion Pharmaceutical Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Jiangsu Kanion Pharmaceutical Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	9425.640	/	4874.333
	=	1.93

Jiangsu Kanion Pharmaceutical Co's current Enterprise Value is ¥9,426 Mil.
Jiangsu Kanion Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥4,874 Mil.

Jiangsu Kanion Pharmaceutical Co (SHSE:600557) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Jiangsu Kanion Pharmaceutical Co's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	18.52	/	8.24
	=	2.25

Jiangsu Kanion Pharmaceutical Co's share price for today is ¥18.52.
Jiangsu Kanion Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥8.24.

Jiangsu Kanion Pharmaceutical Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Jiangsu Kanion Pharmaceutical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Kanion Pharmaceutical Co (SHSE:600557) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Kanion Pharmaceutical Co Ltd (SHSE:600557) » Definitions » EV-to-Revenue

Traded in Other Exchanges

N/A

Address

No. 58 Haichang South Road, Xinpu District, Jiangsu, Lianyungang, CHN, 222001

Website

http://www.kanion.com

Jiangsu Kanion Pharmaceutical Co Ltd focuses on R&D, production and trade of traditional Chinese medicine. The company also makes orthopedics, cardiovascular, anti-infective and anti-tumor products.

Jiangsu Kanion Pharmaceutical Co (SHSE:600557) Headlines

No Headlines